Lindbrook Capital, LLC Biolife Solutions Inc Transaction History
Lindbrook Capital, LLC
- $1.09 Billion
- Q4 2024
A detailed history of Lindbrook Capital, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 96 shares of BLFS stock, worth $2,469. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96
Previous 96
-0.0%
Holding current value
$2,469
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BLFS
# of Institutions
188Shares Held
47.1MCall Options Held
4.3KPut Options Held
4.7K-
Casdin Capital, LLC New York, NY8.71MShares$224 Million19.45% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$141 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.24MShares$83.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$72.9 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.59MShares$41 Million0.21% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.1B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...